Your Subtitle text

ICOO 2018 Schedule
Updated 06/07/2018

Sunday, June 10, 2018 

8:15 am to 9:15 am

KEYNOTE:

Opioid Prescribing Education: Does it Work?

Daniel P. Alford, MD
Associate Professor, Boston University School of Medicine
Boston, MA

9:15 am to 10:00 am

Symptom Management in the Midst of an Opioid Epidemic: An Expert Consensus Guideline
for Safer Opioid Use in Palliative Care

Jenny Lau, MD, CCFP (PC)
Palliative Care Physician, University Health Network
Toronto, Ontario, Canada

Paolo Mazzotta, MD, CCFP (PC)
Palliative Care Physician, Sinai Health System
Toronto, Ontario, Canada

Ciara Whelan, MD, CCFP (PC)
Palliative Care Physician, Sinai Health System
Toronto, Ontario, Canada,

10:30 am to 11:15 am

Rethinking Medication Treatment for Opioid Use Disorder

John A. Renner, MD
Professor of Psychiatry, Boston University School of Medicine, VA Boston Healthcare System
Boston, MA

Dustin Patil, MD
Fellow, Addiction Psychiatry, Boston Medical Center, VA Boston Healthcare System
Boston, MA

Brad Stankiewicz, MD
Fellow, Addiction Psychiatry, Boston Medical Center, VA Boston Healthcare System
Boston, MA

11:15 am to 12:00 pm

Pathway to Treatment and Recovery: Understanding the Role of Warm Handoff Policies and Programs

Shruti Kulkarni, JD
Attorney, DCBA Law and Policy
Washington, DC

Richard C. Dart, MD, PhD
Director, Rocky Mountain Poison & Drug Center, Professor, University of Colorado
Denver, CO

12:00 pm to 12:30 pm

Does Nalbuphine Have a Niche in Managing Pain?

Mellar P. Davis, MD, FCCP, FAAHPM
Director of Palliative Care, Geisinger Medical Center
Danville, PA

1:30 pm to 2:30 pm

Addressing the Opioid Epidemic by Maximizing Behavioral Treatment in Chronic Non-Cancer Pain.

Aleksandra E. Zgierska, MD, PhD
Assistant Professor, Department of Family Medicine, University of Wisconsin-Madison
Madison, WI

Robert Edwards, PhD
Associate Professor, Brigham & Women's Hospital
Chestnut Hill, MA

Eric Garland, PhD, LCSW
Professor, University of Utah
Salt Lake City, UT

2:30 pm to 3:30 pm

The Death of Pain Medicine: What will Pain Medicine look like in the next few decades?

John F. Peppin, DO, FACP, Clinical Adjunct Faculty, Marian University, College of Osteopathic Medicine
Florham Park, NJ

Michael Schatman, PhD, CPE
Director of Research and Network Development, Boston Pain Care
Jamaica Plain, MA

Daniel B. Carr, MD, MA
Professor of Public Health and Community Medicine, Anesthesiology,  Medicine and Molecular Physiology and Pharmacology
Program Director and Founder, Pain, Research Education & Policy, Tufts University
Boston, MA

4:00 pm to 4:30 pm

Engineering Hybrid Peptidomimetics for Improved Pain Treatments.

Steven Ballet, PhD
Professor MedChem, Vrije Universiteit Brussel
Brussels, Belgium

4:30 pm to 5:30 pm

National Pain Strategy Update

Daniel B. Carr, MD, MA
Professor of Public Health and Community Medicine, Anesthesiology, Medicine and Molecular Physiology and Pharmacology
Program Director and Founder, Pain, Research Education & Policy, Tufts University
Boston, MA

5:30 pm to 6:00 pm

Experts Panel

The experts on the panel will answer questions submitted by the audience throughout the day. Daniel B. Carr, MD, MA, Paul Sloan, MD; Richard Dart, MD, PhD, Aleksandra E. Zgierska, MD, PhD 

Monday, June 11, 2018


8:00 am to 8:45 am

Abuse Deterrent Formulations and the Federal (FDA) Response

Raeford E. Brown, Jr., MD, FAAP
Professor of Anesthesiology and Pediatrics, University of Kentucky Medical Center
Lexington, KY

8:45 am to 9:30 am

Emerging Data on Non-Opioid Prescription Drugs that are Abused

Richard C. Dart, MD, PhD
Director, Rocky Mountain Poison & Drug Center
Denver, CO

9:30 am to 10:00 am

Why Are We Still Using Opioids if Opioid Therapy is so Problematic?

Jianren Mao, MD, PhD
Director, Center for Translational Pain Research
Chief, Division of Pain Medicine, Massachusetts General Hospital
Boston, MA

10:30 am to 11:15 am

Now What? Managing Pain in the Presence of Opioid Agonist Therapy

Mary Lynn McPherson, PharmD
Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, University of Maryland-Baltimore
Baltimore, MD

Douglas Gourlay, MD
Educational Consultant, Wasser Pain Management Centre
Toronto, Ontario, Canada

11:15 am to 11:45 am

How to Talk Tapering: Strategies and Treatment Considerations

Jennifer L. Murphy, PhD
Pain Section Supervisor, Tampa VA
Tampa, FL

Nicolle C. Angeli, PhD
Clinical Director, Tampa VA
Tampa, FL

11:45 am to 12:30 pm

Opioid Medication Errors and Harm in Pediatric Practice: Five Years’ Experience of Adverse Event Reporting

David Greaney, MSc, FRCA, FCAI, FJFICMI
Clinical Fellow, Sick Kids
Toronto, Ontario, Canada

1:30 pm to 2:30 pm

            KEYNOTE:

            Opioids for Pain Management and the Public Health Crisis


            Elinore F. McCance-Katz, MD, PhD
            Assistant Secretary for Mental Health and Substance Use
            Substance Abuse and Mental Health Services Administration (SAMHSA)
            Rockville, MD

2:30 pm to 3:30 pm

Not Your Mama's Opioid Conversion Chart! Evidence-Based Opioid Conversion Calculations

Mary Lynn McPherson, PharmD
Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, University of Maryland-Baltimore
Baltimore, MD  

Mellar P. Davis, MD, FCCP, FAAHPM
Director of Palliative Care, Geisinger Health System
Danville, PA

Douglas Gourlay, MD
Educational Consultant, Wasser Pain Management Centre
Toronto, Ontario, Canada

4:00 pm to 4:30 pm

Dual Affinity to Opioid Receptors: From Potent Hallucinogenic Salvinorin A to Promising Analgesic AK-1401

Jordan K. Zjawiony, PhD
Research Professor, Research Institute of Pharmaceutical Science, University of Mississippi
University, MS

James Fajemiroye, PhD
Research Associate, University Center of Anapolis
Anapolis, GO, Brazil

4:30 pm to 5:00 pm

Virtual Reality Therapy Alternative to Opioid Therapy for Pain

Lynn R. Webster, MD, FASAM
Vice President Scientific Affairs, PRA Health Science
Salt Lake City, UT

5:00 pm to 5:30 pm

Experts Panel

The experts on the panel will answer questions submitted by the audience throughout the day. Paul Sloan, MD; Lynn Webster, MD, FASAM, Mary Lynn McPherson, PharmD; Raeford E. Brown, Jr., MD, FAAP 

 

Tuesday, June 12, 2018



8:00 am to 9:00 am

KEYNOTE:
Medical Cannabinoids for the Management of Chronic Noncancer Pain

Mark Ware, MD
Assistant Professor, Anesthesia/Family Medicine, McGill University
Montreal, Quebec, Canada

9:00 am to 9:30 am

Consumption of Prescription Opioids in Belgium (2006-2016).

Hans Willems, PharmD
Pharmacist-inspector at the Medical Evaluation and Inspection Department, National Institute for Health and Disability Insurance
Sint-Pieters-Woluwe, Belgium

Elien De Mooter, MBS
Social-inspector at the Medical Evaluation and Inspection Department, National Institute for Health and Disability Insurance
Sint-Pieters-Woluwe, Belgium

9:30 am to 10:00 am

Long Term Opiate Prescribing after Trauma: The Influence of Injury Burden

Evan Ross, MD
Research Fellow, University of Texas Medical Branch
Galveston, TX

10:30 am to 11:00 am

            Top Three Posters


11:00 am to 11:30 am

Opioid Guidelines

Paul Sloan, MD
Professor of Anesthesiology, University of Kentucky Medical Center
Lexington, KY

11:30 am to 12:30 pm

Primary Care Providers Can Treat Opioid Use Disorder and Help End the Epidemic

Adam Bisaga, MD
Professor of Psychiatry
Columbia University
NYS Psychiatric Institute
New York, NY

(A brief book signing will take place after the Dr. Bisaga's presentation.)


...for the best and brightest minds!



Elinore McCance-Katz, MD, PhD
Assistant Secretary for Mental Health and Substance Use
Office of the Administrator
Substance Abuse and Mental Health Services Administration (SAMHSA)

   
Elinore McCance-Katz, MD, PhD, the first Assistant Secretary of Health and Human Services for Mental Health and Substance Use is set as Keynote Speaker at the seventh annual International Conference On Opioids. She will articulate how the Federal government has developed a multipronged, long-term strategy to address the opioid crisis. 

   Dr. McCance-Katz obtained her PhD from Yale University with a specialty in Infectious Disease Epidemiology and is a graduate of the University of Connecticut School of Medicine. She is board certified in General Psychiatry and in Addiction Psychiatry. She is a Distinguished Fellow of the American Academy of Addiction Psychiatry with more than 25 years as a clinician, teacher, and clinical researcher. Most recently she served as the Chief Medical Officer for the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals and as the Chief Medical Officer for the Eleanor Slater Hospital system which is Rhode Island's state resource for patients with the most serious mental illnesses and medical illnesses requiring long term, inpatient care. She was also Professor of Psychiatry and Human Behavior at Brown University. Previously, she served as the first Chief Medical Officer for the Substance Abuse and Mental Health Services Administration (SAMHSA). Prior to coming to SAMHSA, she served at the University of California, San Francisco as a Professor of Psychiatry, as the Medical Director for the California Department of Alcohol and Drug Programs, and as the Medical Director of SAMHSA's Clinical Support Systems for Buprenorphine (PCSS-B) and Opioids (PCSS-O).

   Dr. McCance-Katz has published extensively in the areas of clinical pharmacology, medications development for substance use disorders, drug-drug interactions, addiction psychiatry, and treatment of HIV infection in drug users. She served on the World Health Organization (WHO) committee that developed guidelines on the treatment of drug users living with HIV/AIDS. She has been a national leader in addressing the overprescribing of opioid analgesics and in providing consultation on management of patients with chronic pain and opioid overuse. She was a participant in the development of SAMHSA TIP 40 which provided the initial guidance to physicians utilizing buprenorphine in the treatment of opioid use disorder, contributed to the development and maintenance of the legislatively required 8 hours of physician training for prescribing buprenorphine products and has continued to be actively involved in the development and delivery of physician training on office-based treatment of opioid use disorders. She has been one of the architects of Rhode Island's plan for addressing the opioid epidemic including new approaches to treatment in the form of a statewide system of Centers of Excellence in the treatment of opioid use disorder, new approaches to training in the utilization of DATA 2000 (Drug Abuse Treatment Act of 2000) to bring DATA waiver training to medical students, and going forward, nurse practitioner and physician assistant students, and legislative/regulatory work addressing safe use of opioids in acute pain.

Join us in Boston...


Daniel P. Alford, MD, MPH

Professor of Medicine, Associate Dean of Continuing Medical Education
Director of the Safe and Competent Opioid Prescribing Education
(SCOPE of Pain) Program
Boston University School of Medicine. 

Keynote Title: Opioid Prescribing Education: Does it Work?

   Daniel P. Alford, MD, MPH is Professor of Medicine, Associate Dean of Continuing Medical Education and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine. 
He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center.

   Dr. Alford is past-president of the Association for Medical Education and Research in Substance Abuse. In 2011 he was recognized as a “Champion of Change” by the White House. In 2014 he received the AMA “Award for Health Education.”

   In 2016, Dr. Alford was awarded the American Society of Addiction Medicine first “Educator of the Year Award” and the American College of Physicians “Award for Distinguished Contributions to Behavioral Medicine”. His clinical, educational and research interests focus on opioid use disorders and safe and competent opioid prescribing for chronic pain.

...for the best and brightest minds!


Dr. Mark Ware, MBBS MRCP

Associate Professor in Family Medicine and Anesthesia, McGill University
Director of Clinical Research, Alan Edwards Pain Management Unit, McGill University Health Centre
Co-Director of the Quebec Pain Research Network
Executive Director, Canadian Consortium for the Investigation of Cannabinoids


   World-renowned pain specialist and medical cannabis researcher Dr. Mark Ware, MBBS MRCP (UK) is a family physician and Associate Professor in Family Medicine and Anesthesia at McGill University. He is the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre, co-Director of the Quebec Pain Research Network, and Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids. Since November 1999, he has been working as a pain physician at the Montreal General Hospital.  


   Dr.  Ware lectures extensively on clinical pain management, including pharmacology, complementary approaches to chronic pain and the neurobiology of pain. 

   In the past 10 years Dr. Ware has given numerous lectures across Canada on pain to health care practitioners and the public. He teaches pain medicine and integrative medicine to medical students at McGill and was recently appointed as a McGill Teaching Scholar to coordinate pain education in the medical school curriculum.

   Dr. Ware’s primary research interests are in evaluating the safety and effectiveness of medicines derived from cannabis (cannabinoids), population-based studies of the impact of pain on the population, and complementary therapies in pain and symptom management
Adam Bisaga, MD
Professor of Psychiatry
Columbia University Medical Center
Curriculum Director
New York State Psychiatric Institute
New York, NY
 
Dr. Adam Bisaga is a Professor of Psychiatry at the Columbia University Medical Center, and a Research Scientist at the New York State Psychiatric Institute.
Dr. Bisaga received his medical degree from Jagiellonian University Medical College in Krakow, Poland. He completed his psychiatric residency at the North Shore University Hospital in Manhasset, NY and his addiction psychiatry fellowship at the Division of Substance Abuse at Columbia University. Here he received training in addiction psychiatry research under the mentorship of Drs. Marian Fischman and Herbert Kleber. Dr. Bisaga became a faculty at the Department of Psychiatry in 1999 and he was promoted to the rank of Professor in 2012.

Dr. Bisaga was a recipient of a Career Development Award and a Principal Investigator on several R01s and Center Grant Projects funded by the National Institute of Dug Abuse in the area of addiction pharmacotherapy development. His research interests include development of human laboratory and clinical trial models and testing medications to treat opioid, cocaine, and tobacco use disorders.

Besides his research contributions Dr. Bisaga’s has been actively involved in teaching medical students and practitioners. He is a Co-Director of an Addiction Psychiatry Fellowship and he is directing a Mentoring Program to train physicians in medication-assistant treatment of addictions (PCSS-MAT). He has been working with UN Office of Drug Control on the development of substance abuse treatment guidelines and conducted trainings for addiction practitioners internationally. In addition to the research and teaching work at the University, Dr. Bisaga also maintains a private practice in addiction psychiatry.


Please bookmark this page and check back periodically.
Schedule Subject to change without notice

 ICOO 2018 Conference Times
Saturday June 9, 2018
 Exhibitor Setup 2:30 pm to 5:00 pm
Attendee Registration 2:30 pm to 5:00 pm
Sunday June 10, 2018
Attendee and Exhibitor Registration 7:00 am to 6:00 pm
Conference day begins at 8:00 am -  day ends at 6:00 pm
Monday, June 11, 2018
Attendee and Exhibitor Registration 7:00 am to 5:00 pm
Conference day begins at 8:00 am - day ends at 5:30 pm
Tuesday, June 12, 2018
 Attendee and Exhibitor Registration 7:00am to 12:30pm
 Conference day begins at 8:00 am - 
Conference closes at 12:30 pm
 Exhibit Breakdown 12:00 pm to 4:00pm